Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Shares withheld for taxes Chief Business Officer gave up 3,326 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Product Strategy Officer gave up 3,326 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 2,861 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,324 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Fin. & Admin Officer gave up 3,326 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 7,484 shares (to pay taxes)
  10. 4 Open-market buy President and CEO bought 45,000 shares at $5.69 ($256,050)
  11. 4 Planned sale Chief Product Strategy Officer sold 2,283 shares at $8.06 ($18,401)
  12. 4 Planned sale Chief Business Officer sold 2,283 shares at $8.06 ($18,401)
  13. 4 Planned sale Chief Medical Officer sold 866 shares at $8.06 ($6,980)
  14. 4 Planned sale Chief Scientific Officer sold 2,591 shares at $8.06 ($20,883)
  15. 4 Planned sale Chief Fin. & Admin Officer sold 2,591 shares at $8.06 ($20,883)
  16. 4 Planned sale President and CEO sold 5,142 shares at $8.06 ($41,445)
  17. 4 Shares withheld for taxes Chief Business Officer gave up 753 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Product Strategy Officer gave up 753 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,595 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Fin. & Admin Officer gave up 1,595 shares (to pay taxes)

Page 3 of 24 · 475 filings